Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer
Open Access
- 16 December 1993
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (25) , 1848-1852
- https://doi.org/10.1056/nejm199312163292504
Abstract
Moderate increases in the initial doses of certain chemotherapeutic drugs, such as cisplatin and cyclophosphamide, may prolong overall survival in patients with limited small-cell lung cancer.Keywords
This publication has 27 references indexed in Scilit:
- High-dose chemotherapy in solid tumoursAnnals of Oncology, 1993
- Dose intensity of initial chemotherapy may have an impact on survival in limited small cell lung carcinomaLung Cancer, 1993
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerThe Lancet, 1992
- Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.Journal of Clinical Oncology, 1992
- TNM AtlasPublished by Springer Nature ,1989
- Policies for study monitoring and interim reporting of results.Journal of Clinical Oncology, 1987
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958